S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,229.76 (+2.37%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)

These Were The Ten Best Performing IPOs In Q1 2022

Last updated on Saturday, April 23, 2022 | 2022 ValueWalk

IPO market witnessed a slowdown in Q1 2022, and there are several reasons for this. These reasons include rising geopolitical tensions, rising commodity and energy prices, rising inflation, stock market volatility and price correction in over-valued stocks from recent IPOs. Despite the grim scenario, 37 deals were completed in the U.S. in Q1 2022, raising $2.4 billion in proceeds.  Let’s take a look at the ten best performing IPOs in Q1 2022.

Q1 2022 hedge fund letters, conferences and more

Ten Best Performing IPOs In Q1 2022

We have used the quarterly return data (from finviz.com) of companies that went public in Q1 2022 to rank the ten best performing IPOs in Q1 2022. Following are the ten best IPOs in Q1 2022:

  1. Green Visor Financial Technology Acquisition (1%)

Founded in 2021 and headquartered in San Francisco, Green Visor Financial Technology Acquisition (NASDAQ:GVCIU) is a blank check company that has been formed for effecting a merger, share purchase, asset acquisition and other similar transactions. Its shares are currently trading over $10 and are up almost 1% in the last one month.

  1. Bullpen Parlay Acquisition (2%)

Bullpen Parlay Acquisition Co (NASDAQ:BPAC) is a blank check company that has been formed for the purpose of effecting a merger, asset acquisition, stock purchase, or other similar transactions. Its shares are currently trading over $9.90 and are up almost 1% in the last one month.


  1. NorthView Acquisition (2%)

Founded in 2021 and headquartered in New York, it is a blank check company that is formed to effect a merger, asset acquisition, share purchase, or other similar transactions. Northview Acquisition Corp (NASDAQ:NVAC) shares are currently trading over $9.80.

  1. Mount Rainier Acquisition (2%)

Founded in 2021 and headquartered in New York, it is a blank check company or a special purpose acquisition company formed with the purpose of effecting a merger, asset acquisition or other similar transactions. Mount Rainier Acquisition Corp (NASDAQ:RNER) shares are up almost 1% in the last one month. Its shares are currently trading over $10.

  1. CareCloud (4%)

Founded in 1999 and headquartered in Somerset, N.J., it is a healthcare information technology (IT) company that offers an integrated suite of proprietary cloud-based electronic health records and practice management solutions. CareCloud Inc (NASDAQ:MTBC) shares are down almost 3% in the last one month and almost 1% in the last five days. Its shares are currently trading over $25.70. CareCloud completed the offering of Series B Preferred Stock in early February.

  1. CinCor Pharma (13%)

Founded in 2018 and headquartered in Boston, it is a clinical-stage biopharmaceutical company that develops clinical treatments for hypertension and other cardio-renal diseases. CinCor Pharma Inc (NASDAQ:CINC) shares are up almost 19% in the last one month but are down over 4% in the last five days. The company went public in the first week of January.

  1. Presidio Property Trust (22%)

Founded in 1999 and headquartered in San Diego, it is a self-managed real estate investment trust that invests across a multi-tenant portfolio of real estate assets. Presidio Property Trust Inc (NASDAQ:SQFT) shares are down over 1% in the last one month. Its shares are currently trading over $0.20.

  1. Credo Technology Group Holding (24%)

Founded in 2014 and headquartered in San Jose, Calif., this company offers connectivity solutions and products for the data infrastructure market, such as integrated circuits, active electrical cables and more. Credo Technology Group Holding Ltd (NASDAQ:CRDO) shares are down over 21% in the last one month. Its shares are currently trading over $11.90, giving it a market cap of over $1.5 billion. Credo Technology Group went public in the last week of January.

  1. Constellation Energy (38%)

Headquartered in Baltimore, this company generates, supplies and markets clean energy electricity, as well as offers renewable energy products and solutions. Constellation Energy Corp (NASDAQ:CEG) shares are up almost 25% in the last one month and almost 5% in the last five days. Its shares are currently trading over $64, giving it a market cap of over $21 billion. Constellation Energy went public in early February.

  1. Nuvectis Pharma (116%)

Founded in 2020 and headquartered in Fort Lee, N.J., it is a preclinical stage biopharmaceutical firm that focuses on novel targeted small molecule therapeutics for treating cancer. Nuvectis Pharma Inc (NASDAQ:NVCT) shares are up almost 28% in the last one month but are down almost 5% in the last five days. Its shares are currently trading over $9.50, giving it a market cap of over $120 million. Nuvectis Pharma went public in early February.


7 Mid-Cap Stocks to Buy For When the Fed Gets Serious

How should you be investing in 2022? It's a near certainty that the Fed will continue to pursue a more hawkish monetary policy for the rest of 2022. And right now the market is expecting interest rate increases to start in March 2022.

The thought that the Fed will take aggressive measures to combat inflation is still weighing on growth-minded investors? After all, stocks still look like the place to be.

If you're an investor looking to maximize your growth this year, you should first make sure you have a base of blue-chip stocks. These stocks can deliver solid returns no matter how the broader market goes. However, after that, you should still have your eyes on growth. And mid-cap stocks may be just the place to look.

Mid-cap stocks are defined by companies with a market capitalization between $2 billion and $10 billion. These companies are still in the growth phase so they're putting their profits to work in growing their business.

The recent market sell-off has put many of these stocks at attractive points. And while many of them still don't qualify as oversold by technical measures, they are offering significant upside at their current price points.

At some point the Fed is likely to get serious about whipping inflation. When it does, investors will become even more selective than they already are. By investing in these mid-cap stocks, you can stay one step ahead of whatever comes next.



View the "7 Mid-Cap Stocks to Buy For When the Fed Gets Serious".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Bullpen Parlay Acquisition (BPAC)
0 of 5 stars
$9.87-0.3%N/AN/AN/AN/A
NorthView Acquisition (NVAC)
0 of 5 stars
$9.87+0.3%N/AN/AN/AN/A
Mount Rainier Acquisition (RNER)
0 of 5 stars
$9.99-0.1%N/AN/AN/AN/A
CareCloud (MTBC)
2.3564 of 5 stars
$3.99+1.0%N/A-6.44Buy$15.33
CinCor Pharma (CINC)
1.8667 of 5 stars
$15.13-11.6%N/AN/ABuy$29.00
Presidio Property Trust (SQFT)
1.7583 of 5 stars
$3.04+0.3%13.82%-6.08Buy$2.75
Credo Technology Group (CRDO)
1.9314 of 5 stars
$10.00+3.1%N/AN/ABuy$20.75
Nuvectis Pharma (NVCT)
2.0333 of 5 stars
$15.89+2.5%N/AN/ABuy$21.00
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.